Ungayakha Kanjani Impilo Ehlangene, Ukubuyiselwa Kwezemidlalo kanye Nemikhiqizo Eguga Enempilo nge-Liposomal Curcumin

Kubaphathi bokuthengwa kwempahla kanye namaqembu okwakhiwa athuthukisa imikhiqizo yokunethezeka ngokuhlanganyela, ukululama kwezemidlalo, nokuguga okunempilo, i-curcumin sekuyisikhathi eside yaziwa ngezakhiwo zayo zokulwa nokuvuvukala kanye ne-antioxidant. Nokho ukwakheka okujwayelekile kwe-curcumin kube nzima ukuletha imiphumela yomtholampilo engaguquki ngenxa yokungatholakali kahle kwe-oral bioavailability.I-Liposomal curcumin powderibhekana nalo mkhawulo ngokusebenzisa i-phospholipid encapsulation, okuvumela abaklami ukuba bathuthukise imikhiqizo enezinzuzo zokumuncwa ezibhaliwe kanye nezinzuzo zabathengi ezilinganisekayo. Kodwa-ke, ubufakazi obandayo buphakamisa ukuthi ubuchwepheshe bokwenza{1}hhayi nje ukuhlanzeka kwe-curcumin{2}}buba ngumehluko oyinhloko wemikhiqizo ye-premium. Imakethe ye-curcumin yomhlaba wonke kulindeleke ukuthi ikhule isuka ku-$98.9 million ngo-2024 iye ku-$199.7 million ngo-2030 ku-CAGR ye-11.9%. Ngaphakathi kwalesi sigaba esikhulayo, amafomethi e-liposomal kanye namafomethi okulethwa athuthukile abamba isabelo esikhulayo njengoba abadidiyeli bebona ukuthi i-bioavailability{10}hhayi nje ukuhlanzeka kwesithako{11}okunquma ukusebenza komkhiqizo ophelile.

 

 

 

• I-Liposomal curcumin powderifinyelela ukuchayeka kwesistimu okuphakeme kakhulu kunokukhishwa okujwayelekile, ngokwakheka okukodwa okubonisa ukufinyeleleka kwe-bioaccessibility okuphindwe izikhathi ezingu-11 uma kuqhathaniswa ne-curcumin eluhlaza.
• Ucwaningo lwezokwelapha lubonise ukuthi i-curcumin inganciphisa ubuhlungu be-osteoarthritis yamadolo ngokuqhathaniswa ne-ibuprofen ngezikhathi ezimfushane zokulandelela (imvamisa amaviki angu-4-8), ngephrofayili yomphumela ohlukile ohlukile.
• Ebantwini asebekhulile, ukwesekwa kwe-curcumin kuye kwahlotshaniswa nokunciphisa okuphawulekayo ku-C-reactive protein (CRP) (p = 0.03), umfutho wegazi we-systolic (p = 0.04), kanye noshukela wegazi lokuzila ukudla (p = 0.02).
• Ukubuyekezwa okuhlelekile kukhombisa ukuthi i-curcumin supplementation (150‑1500 mg/day) inganciphisa ukulimala kwemisipha okwenziwa ukuzivocavoca futhi ishintshe ukuvuvukala okubangelwa umsebenzi womzimba.
• Kubathengi be-B2B, imibandela yokuhlola ebalulekile ihlanganisa ukusebenza kahle kwe-encapsulation, okuqukethwe kwe-curcuminoid okuqinisekisiwe kwe-HPLC, ukusatshalaliswa kosayizi wezinhlayiyana, kanye nemibhalo yokuhlaziya ethize yeqoqo.

 

 

Isigaba sesengezo sezempilo esihlanganyelwe simele izimakethe ezinkulu nezisungulwe kakhulu zemikhiqizo esekelwe ku-curcumin. Ubufakazi bomtholampilo obusekela indima ye-curcumin empilweni ehlanganyelwe buye banda kakhulu kule minyaka eyishumi edlule.

Ubufakazi Bomtholampilo ku-Osteoarthritis

Ukubuyekezwa okuhlelekile kwe-2025 kanye nokuhlaziywa kwe-meta-network kuqinisekisile ukuthi imikhiqizo ye-turmeric iye yahlolwa njengokwelashwa kwe-knee osteoarthritis ezivivinyweni ezihlukahlukene ezilawulwa ngokungahleliwe ngenxa yezakhiwo zabo ezaziwayo zokulwa nokuvuvukala. I-Curcumin iboniswe ukuthi iholele ekunciphiseni kwe-serum CRP kanye namazinga e-TNF-alpha ezigulini ezine-knee osteoarthritis.

Isilingo sango-2025 esingahleliwe, esingaboni kabili, esilawulwa yi-placebo esihlola inoveli enomthamo ophansi wamanzi-dispersible turmeric extract kubahlanganyeli abane-knee osteoarthritis emaphakathi ukuya kokumaphakathi ibike ukusebenza kahle kanye nemiphumela yokuphepha. Olunye ucwaningo lwango-2025 lwathola ukuthi ukwakheka kwe-curcumin okusekelwe kubuchwepheshe be-LIMAN kuyo yomibili imithamo eyi-100 mg kanye ne-250 mg yayisebenza kahle futhi yabekezelelwa kahle ekulawuleni i-knee osteoarthritis.

Ukuhlola okungahleliwe kubonise ukuthi i-curcumin inganciphisa ubuhlungu be-osteoarthritis edolweni cishe obulingana ne-ibuprofen ezikhathini zokulandelela ezifushane (imvamisa amaviki angu-4-8), ngephrofayela ehlukile yomphumela ongaseceleni-umbalwa ukopha kwe-GI nokukhathazeka kwezinso.

Amathuba Okwakha Ezempilo Ezihlangene

Umqondo Womkhiqizo	Inzuzo Yomthengi Ebalulekile	Kunconywe I-Liposomal Curcumin Dose
Amaphilisi asekela ahlangene nsuku zonke	Igcina ukunethezeka okuhlangene kanye nokuhamba	100‑250 mg curcuminoids ngokuphakela ngakunye
Impilo ehlangene ethuthukisiwe ne-boswellia	Ukwesekwa okuphelele kokuvuvukala	150-250 mg nama-boswellic acid
Ukubuyiselwa okuhlangene nge-collagen	Isekela uqwanga kanye nezicubu ezixhumeneyo	100-200 mg nge-collagen e-hydrolyzed
Ama-creams ahlangene we-topical	Usekelo lwasendaweni oluqondisiwe	Ukwakhiwa kwe-Liposomal ukuze kungene okuthuthukisiwe

Ucwaningo lwe-preclinical luphakamisa ukuthi i-curcumin ingasiza ekugcineni ubuqotho bezicubu ezixhumene futhi iguqule izindlela zokuvuvukala ezihambisana nempilo ehlangene. Kubakhiqizi be-B2B, lokhu kubeka i-liposomal curcumin njengesithako esiyisisekelo sokwakheka kwezempilo okuhlangene okuqondise kubathengi asebekhulile kanye nabantu abadala abakhuthele.

 

 

Ukusetshenziswa kwe-curcumin ekudleni kwezemidlalo kukhule kakhulu njengoba ucwaningo luye lwacacisa indima yalo ekulungiseni ukuvuvukala okubangelwa ukuvivinya umzimba kanye nokulimala kwemisipha.

Izindlela Zokubuyisela Imisipha

I-Curcumin supplementation (i-150-1500 mg / ngosuku) ngaphambi nangesikhathi sokuzivocavoca, futhi kuze kufike emahoreni angu-72 ngemva kokuzivocavoca, kuboniswe ukuthuthukisa ukusebenza ngokunciphisa ukulimala kwemisipha okubangelwa ukuvivinya umzimba kanye nokulinganisa ukuvuvukala okubangelwa umsebenzi womzimba. Ukubuyekezwa okuhlelekile nokuhlaziywa kwe-meta kuphethe ngokuthi i-curcumin ikhombisa amandla amakhulu okudambisa izimpawu ezihlobene nemisipha, ikakhulukazi ukubambezeleka-ukuqala kobuhlungu bemisipha (DOMS) obuvela ekuzilolongeni kwe-eccentric.

Izindlela zibandakanya ukulawulwa kwezindlela ze-NF-κB ne-Nrf2, ezilawula izimpendulo zokuvuvukala nokuzivikela kwe-antioxidant. I-Curcumin supplementation ihlotshaniswa nokwehliswa kwama-biomarker wokuzivocavoca{2}}okubangelwa ukulimala kwemisipha ezifundweni ezimbalwa.

Amathuba Okwakha Okuthola Ezemidlalo

Umqondo Womkhiqizo	Inzuzo Yomthengi Ebalulekile	Kunconywe I-Liposomal Curcumin Dose
Impushana yokutakula ngemva kokujima	Yehlisa ubuhlungu bemisipha futhi isheshise ukululama	150‑300 mg curcuminoids ngokuphakela ngakunye
Pre-exercise anti-inflammatory capsules	Iqinisa umzimba ngokucindezeleka okubangelwa ukuzivocavoca	100-200 mg pre-exercise
Amashothi okubuyisela (iziphuzo ze-RTD)	Usekelo olulula, olusebenza ngokushesha lokutakula	100‑200 mg ngefomethi yoketshezi
Ama-gummies okubuyisela	Ifomethi ethandekayo yabasubathi	100-150 mg ngokuphakela ngakunye

Okuqukethwe Okubalulekile Kwabaqulunqi

Ngenkathi i-curcumin ibonisa isithembiso sokululama, ubufakazi abufani kuyo yonke imiklamo yocwaningo. Olunye ucwaningo luye lwabonisa ukuthi i-curcumin ingase ingasheshisi ukutakula ekulimaleni kwemisipha kuzo zonke izigaba zezemidlalo. Kodwa-ke, ukubuyekezwa okuhlelekile kusekela ngokuqhubekayo indima yokuvikela ye-curcumin elandela umsebenzi womzimba, ikakhulukazi ekunciphiseni umbono oqondile wokuqina kobuhlungu bemisipha. Kubathengi be-B2B, lokhu kuphakamisa ukuthi i-liposomal curcumin ibekwe kangcono njengengxenye yokwakheka okuphelele kokululama kunesixazululo esizimele.

 

 

Imakethe yokuguga enempilo imele ithuba elibalulekile lokukhula kwe-liposomal curcumin, eqhutshwa amandla e-compound okulinganisa ukuvuvukala kwebanga eliphansi kanye nokusekela impilo ye-metabolic kubantu asebekhulile.

Ubufakazi Bomtholampilo Kubantu Abadala

Ukubuyekezwa okuhlelekile kwango-2025 kokuhlolwa okulawulwa ngokungahleliwe okuhlola ukwesekwa kwe-curcumin kubantu asebekhulile kuthole ukuthuthukiswa okuphawulekayo kumakaki ambalwa we-metabolic kanye nokuvuvukala, okuhlanganisa ukuncipha kwe-C‑reactive protein (CRP) (p = 0.03), umfutho wegazi we-systolic (p = 0.04), ushukela wegazi ozila ukudla (p = 0.02 uqhathaniswa nokulawula{}}, kanye ne-IR.

Ucwaningo lwango-2025 oluhlola ukuqeqeshwa kwamandla okumelana nokuqina okuhlangene nokwengezwa kwe-curcumin kubantu abadala asebekhulile lwathola ukuthi i-curcumin ithuthukisa izinzuzo zezinhlelo zokuqeqesha ukumelana, iphakamisa izinzuzo ezingaba khona zesimo se-antioxidant, ukusebenza kwemisipha nokuguga okunempilo uma kuhlanganiswa nokuqeqeshwa kokumelana.

Ukuvuvukala kanye Nempilo Yengqondo

Nakuba imiphumela elwa nokuvuvukala ye-curcumin isungulwe kahle, izinzuzo ezingase zibe khona zokucatshangelwa zihlolwe kamuva nje. Ukubuyekezwa kuka-2025 kukhombe izivivinyo ezilawulwa ngokungahleliwe ezihlola umphumela we-curcumin ekuqondeni, nocwaningo oluthile olubona imiphumela enenzuzo kwinkumbulo yokusebenza. Nakuba ubufakazi busavela, lokhu kumelela isiqondiso esithembisayo sokuguga okunempilo okuphambili.

Amathuba Okwakha Okuguga Okunempilo

Umqondo Womkhiqizo	Inzuzo Yomthengi Ebalulekile	Kunconywe I-Liposomal Curcumin Dose
Amaphilisi okuguga anempilo nsuku zonke	Isekela impilo ye-metabolic kanye nebhalansi yokuvuvukala	150‑300 mg curcuminoids ngokuphakela ngakunye
Ukwesekwa kwezempilo kwengqondo	Isekela inkumbulo yokusebenza nempilo yobuchopho	150-250 mg nge-omega-3 fatty acids
Ukwakhiwa kwe-Metabolic Wellness	Isekela i-glucose metabolism kanye nempilo yenhliziyo	200-300 mg nge-berberine noma i-chromium
Ubuhle‑kusuka-ngaphakathi kwamaphilisi	Isekela impilo yesikhumba kanye nokuqina kwamaselula	100-200 mg nge-collagen noma i-hyaluronic acid

 

 

Ukuhlanganisa i-liposomal curcumin nezithako ezihambisanayo kungathuthukisa ukusebenza kahle kokwakheka futhi kusekele izimangalo zezempilo ezibanzi.

Inhlanganisela efakazelwe ye-Synergistic

Isithako	I-Synergistic Mechanism	Ukucatshangelwa Kokwakhiwa Okujwayelekile (vs. Curcumin)
I-Boswellia serrata	Ukuguqulwa kwendlela yokuvuvukala okuhambisanayo	Ububanzi obujwayelekile bokubunjwa (i-curcumin:boswellia)
I-Piperine	Ukuthuthukiswa kwe-Bioavailability (akubalulekile kangako ngokulethwa kwe-liposomal)	1:10 (piperine:curcumin) noma yeqa
I-Resveratrol	I-antioxidant ehambisanayo ne-sirtuin activation	Ububanzi obujwayelekile bokubunjwa
I-Quercetin	Usekelo lwe-Synergistic anti-inflammatory and senolytic	Ububanzi obujwayelekile bokubunjwa
Ama-collagen peptides	Ukusekelwa kwesakhiwo esihlangene nesikhumba	Okuguquguqukayo okususelwa kusidingo samaprotheni
I-Omega-3 fatty acids	Ukuguquguquka kokuvuvukala okuhambisanayo	Iyaguquguquka

I-Piperine ivame ukusetshenziswa ekwakhiweni okujwayelekile kwe-curcumin ukuze kuthuthukiswe i-bioavailability. Kodwa-ke, ngezinhlelo zokulethwa kwe-liposomal, isidingo se-piperine siyancishiswa, sisekela ukuma kwelebula ehlanzekile futhi kugwenywe ukukhathazeka okungenzeka kube nokusebenzisana kwezidakamizwa.

 

 

Ukuguquguquka kwe-liposomal curcumin powder kwenza ukwakheka kuwo wonke amafomethi womkhiqizo amaningi, ngalinye linezidingo zobuchwepheshe ezihlukile.

Amaphilisi kanye namathebulethi

Amaphilisi ahlala eyifomethi ehamba phambili yezithako ze-curcumin. I-Liposomal curcumin powder ingafakwa ngokuqondile emisebenzini evamile yokugcwalisa i-capsule, enesisindo sokugcwalisa esijwayelekile se-300-500 mg nge-capsule ngayinye kuye ngokugxila kwe-curcuminoid.

Iziphuzo ezisebenzayo namaShots

Ukuhlakazeka kwamanzi okuthuthukisiwe kwe-Liposomal curcumin kwenza ukuhlanganiswa namashothi okulungele ukuphuza (RTD) nezimpushana. Ucwaningo lwe-2025 lubike ukuthi i-curcumin liposome powder ithuthukise kakhulu ukufinyeleleka kwe-curcumin, yafinyelela cishe izikhathi ezingu-11 ze-curcumin eluhlaza kanye nezikhathi ezingu-4 ezitholakala ngokuthengisa i-curcumin ephezulu yokumunca. Lokhu kwenza i-liposomal curcumin ifaneleke ikakhulukazi ukufakwa kwesiphuzo lapho i-curcumin evamile ingadaleka noma ihlehle.

Ama-Gummies kanye nama-Chewables

Ifomethi ye-gummy iyaqhubeka nokukhula ngokushesha emakethe yezengezo. I-Liposomal curcumin powder ingafakwa kuma-gummy matrices ngokuzinzisa okufanele, inikeze inketho ethandekayo kubathengi abakhetha amafomethi angawahlafuna.

Ama-Sachets nama-Stick Pack

Amafomethi empushana esetshenziswa kanye kuphela aya ngokuya aduma kubathengi abasendleleni. Izici ezigeleza mahhala ze-Liposomal curcumin powder kanye nokuhlakazeka kwamanzi kuyenza ifanelekele ukusetshenziswa kwephakethe lezinti.

 

 

 

Kubathengi be-B2B, ikhwalithi ye-liposomal curcumin powder incike emandleni obuchwepheshe bomphakeli kanye nezinhlelo zekhwalithi.

Imibandela Yokuhlola Ebalulekile

• Okuqukethwe kwe-curcuminoid okuqinisekisiwe kwe-HPLC:Imvamisa ukugxila okungu-50% noma okungu-70%, okunamaphrofayili abhaliwe e-curcumin, i-demethoxycurcumin, ne-bisdemethoxycurcumin.
• Ukusebenza kahle kwe-Liposomal encapsulation:Kuqinisekiswe ngezindlela zokuhlaziya eziqinisekisiwe. Ukusebenza kahle kwe-encapsulation kungenye yezinkomba ezibaluleke kakhulu zokuhlola ikhwalithi yokwakheka kwe-liposomal.
• Ukusabalalisa usayizi we-particle:Idatha ye-Dynamic light scattering (DLS) ebonisa usayizi wezinhlayiyana ezifanayo kanye nenkomba ye-polydispersity ephansi.
• Umthombo nekhwalithi ye-Phospholipid:Ubhekilanga okungewona we-GMO noma i-soy lecithin enokuqukethwe okubhaliwe kwe-phosphatidylcholine.
• Idatha yokuzinza:Izifundo zokuzinza ezithobela i-ICH ezibonisa ukugcinwa kwamandla esikhathini seshelufu (izinyanga ezingu-24 ezijwayelekile).
• Amadokhumenti okuhlaziya:Izitifiketi Zokuhlaziya eziqondene neqoqo (COA) ezihlanganisa ukuhlaziywa kwensimbi enzima (ICP-MS), idatha yokuphepha kwe-microbiological, nemibiko yensalela yencibiliki.
• Izitifiketi nokuhambisana:cGMP, ISO 22000, FSSC 22000, HACCP, Kosher, Halal, Non-GMO Project Iqinisekisiwe njengoba isebenza.

Amandla Okukhiqiza Kwezentengiso

Hlola ikhono lomphakeli lokukala kusukela kumaqoqwana okuhlola kuye kumavolumu okukhiqiza ezentengiso kuyilapho ugcina ukufana kweqoqo nenqwaba kanye namazinga ekhwalithi.

 

 

Kubaphathi bokuthenga be-B2B nabathuthukisi bomkhiqizo, i-liposomal curcumin powder inikeza isiteji esiqinisekisiwe ngokwesayensi sokwenza impilo ehlangene, ukutakula kwezemidlalo, nemikhiqizo yokuguga enempilo. I-curcumin evamile ibonise umsebenzi webhayoloji ezifundweni eziningi zomtholampilo-okuhlanganisa ukuncipha kobuhlungu be-osteoarthritis obuqhathaniswa ne-ibuprofen, ukuthuthukiswa kwezimaka ezivuvukalayo kubantu abadala, kanye nokuguqulwa kokulimala kwemisipha okudalwe ukujima{3}}kodwa ukulinganiselwa kwayo kwe-bioavailability kuye kwavimbela impumelelo yezohwebo ngokomlando. I-Liposomal encapsulation ibhekana naleli gebe, ngocwaningo olulodwa olubika cishe ukufinyeleleka okuphezulu okuphindwe izikhathi eziyi-11 uma kuqhathaniswa ne-curcumin eluhlaza. Ukuguquguquka kwe-liposomal curcumin powder kwenza ukwakheka kuwo wonke ama-capsules, iziphuzo, ama-gummies, nama-sachets, okusekela ukuhlukaniswa komkhiqizo ezigabeni zokuncintisana. Ngokubambisana nomphakeli obonisa izinto ngobuchwepheshe ohlinzeka ngamadokhumenti okuhlaziya aqinisekisiwe, idatha ye-encapsulation esebenza kahle, kanye nesitifiketi esikhethekile seqoqo, abakhiqizi bangakha amafomula ahlukene asekelwa ubufakazi besayensi obushicilelwe kanye nemibhalo yesithako eqinisekisiwe.

 

 

• Amaklayenti amaningi aqala ngeqoqo lokuhlola (100‑500 g) ukuze aqinisekise ukuhlakazeka, ukuzinza, nokusebenza kokwakheka ku-matrix yawo ethile ngaphambi kokukalela ekukhiqizeni ezentengiso. I-COA eqondene neqoqo, idatha yosayizi wezinhlayiyana, kanye nezifundo zokuzinza kuyatholakala ukuze kusekelwe inqubo yokuthuthukisa umkhiqizo wakho.
• [Cela amasampula amaningi e-liposomal curcumin]- Hlola amamaki ethu e-liposomal curcumin powder (50% noma 70% curcuminoids) ku-matrix yakho yokubunjwa.
• [Finyelela kumadokhumenti wobuchwepheshe]- Buyekeza imibiko yokuhlola ye-HPLC, ukusatshalaliswa kosayizi wezinhlayiyana (i-DLS), idatha ye-encapsulation esebenzayo, ukuhlaziywa kwensimbi esindayo, kanye nezifundo zokuzinza.
• [Xoxa ngokucaciswa ngokwezifiso]- Hlola ukugxila ngokwezifiso, izinketho ze-liposomal encapsulation, noma ukusekelwa kokwakhiwa.
• [Shejula ukubonisana kokwakhiwa]- Hlangana nethimba lethu le-R&D ukuze ubhekane ne-curcumin bioavailability, ukuzinza, noma izinselelo eziqondene nohlelo lokusebenza.

Kungakhathaliseki ukuthi wenza amaphilisi, amaphakethe okunamathela, ama-gummies, amaphilisi, noma ukwakheka kwesiphuzo esisebenzayo, ithimba lethu lezobuchwepheshe lingasiza ekuhloleni ukucaciswa kwempushana ye-liposomal curcumin efaneleke kakhulu yephrojekthi yakho.

I-MOQ, isikhathi sokuhola, kanye namanani entengo amaningi atholakala uma ucela. I-Wellgreen inikeza i-COA eqondene nenqwaba, ukuhlaziywa kosayizi wezinhlayiyana, usekelo lokwakhiwa kanye nezinsizakalo ze-OEM/ODM kubakhiqizi bomhlaba wonke bezomsoco. Ukuze uthole ukwesekwa kobuchwepheshe, ukubonisana nokuklama, namakhotheshini ayinqwaba, xhumana nethimba lethu lonjiniyela kuliu@wellgreenxa.com.

 

 

1. Anand, P., Kunnumakkara, AB, Newman, RA, & Aggarwal, BB (2007). I-Bioavailability ye-curcumin: izinkinga nezithembiso.I-Molecular Pharmaceutics, 4(6), 807-818. PMID: 17999464.
2. Ireson, CR, Jones, DJL, Orr, S., et al. (2002). I-Metabolism yomdlavuza we-chemopreventive agent curcumin emathunjini omuntu namagundane.Ucwaningo lweCancer, 62(16), 4595-4599. PMID: 12183412.
3. Wang, YJ, Pan, MH, Cheng, AL, et al. (1997). Ukuzinza kwe-curcumin kuzixazululo ze-buffer kanye nokubonakaliswa kwemikhiqizo yayo yokuwohloka.Ijenali Yokuhlaziywa Kwemithi kanye Nezokwelapha, 15(12), 1867-1876. PMID: 9278892.
4. Tonnesen, HH, & Karlsen, J. (1991). Izifundo ze-curcumin ne-curcuminoids. VI. I-Kinetics yokuwohloka kwe-curcumin kusisombululo esinamanzi.I-Zeitschrift für Lebensmittel‑Untersuchung kanye ne-Forschung, 192(3), 237-240.
5. Sneharani, AH, et al. (2022). I-bioavailability yomlomo ethuthukisiwe ye-curcumin ngama-liposomes ahlanganiswe ne-chitosan.Ijenali Yomhlaba Wonke Yezemithi, 622, 121654.
6. Imiphumela ye-curcumin kuma-biomarker we-serum ukuvuvukala ezigulini ezine-knee osteoarthritis: ukubuyekezwa okuhlelekile nokuhlaziywa kwe-meta-analysis yezilingo ezilawulwa ngokungahleliwe. (2025).I-PubMed. I-Curcumin yehlise i-serum CRP namazinga e-TNF-alpha.